1
by Chao, Yi-Sheng, Spry, Carolyn
Published 2018
Canadian Agency for Drugs and Technologies in Health
... to have comprehensive understanding of the potential health benefits of preventative foot care, this study...

2
by Chao, Yi-Sheng, Spry, Carolyn
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Cost-Benefit Analysis...

3
by Chao, Yi-Sheng, MacDougall, Danielle
Published 2019
CADTH
...This report aims to review the evidence regarding the clinical utility and cost-effectiveness...

5
by Chao, Yi-Sheng, Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Health Services Accessibility...

6
by Chao, Yi-Sheng, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
... and hemostasis are affected by myometrial contractions. Prophylactic use of uterotonics is the standard of care...

7
by Chao, Yi-Sheng, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
... and hemostasis are affected by myometrial contractions. Prophylactic use of uterotonics is the standard of care...

8
by Chao, Yi-Sheng, Visintini, Sarah
Published 2018
CADTH
... less effective and fail to maintain disease remission. In these cases, dose intensification or more...

10
by Chao, Yi-Sheng, Grobelna, Aleksandra
Published 2018
CADTH
..., the essential and basic medications needed in health care. There is some evidence that porcine-derived...